ArticleAnnals of translational medicine2021

Additional chemotherapy improves survival in stage II-III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis.

Yanhong Cen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.